Yes agreed @GazD. Seems like a few people had their crystal balls working beautifully a week ago, before today's announcement. Hopefully the announcement gets a funding deal or two done now though, so no more capital raising dilution is required to complete the phase 3.

Also, we probably don't want the share price to go up again until next week, as there are a bunch of options due to expire on Nov 30th, with an exercise price of 65c. If they were all exercised it would create another 13% of new shares to be issued and in turn dilute all holders that amount, so hopefully it can stay just under that for a couple of days!!!

Ooohhh… who would have considered those options could be in the money… nice point @Karmast

I would have kinda liked the PAR options to get triggered at $0.65+ but seems unlikely the price will rise the required 50% to get there by 4pm today!

That would have diluted existing shareholders but effectively raises at a price higher than today and 50% higher than the $0.43 at the last raise.

If all 13% exercised at $0.65, this would bring in about AU$40m by my calcs - about half the expected trial costs over 2 years.

The big win from this would be the breathing room and negotiating power PAR would have to extract a good deal for shareholders from trial and commercialisation partners.

But in the end you can want what ever you like, we'll get what we're given by Mr Market and his merry band of mischief makers.

“Experience is what you get when you didn't get what you wanted.” - Randy Pausch